Nyxoah Reports Preliminary Q2 Global Net Revenue Of ~€7.7M, Reiterates FY26 Global Net Revenue Range €36M - €40M
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ("Nyxoah" or the "Company"), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through
